In this issue of Blood , Andreas Tiede et al report the results of a German, Austrian, and Swiss registry (GTH-AH study) of acquired hemophilia and identify prognostic factors that may guide the choice of immunosuppressive treatment (IST) to eradicate the autoantibody contributing to the outcome of
No takes yet. Share an insight, caveat, or question.
Baudo et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: